Massachusetts Financial Services CO Edwards Lifesciences Corp Transaction History

Massachusetts Financial Services CO

$314 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$82.37 - $107.29 $55.3 Million - $72.1 Million	-671,801 Reduced 12.48%	4,709,248 $389 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $74.4 Million - $110 Million	860,313 Added 19.03%	5,381,049 $512 Million
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $4.5 Million - $5.67 Million	-44,165 Reduced 0.97%	4,520,736 $532 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $3.5 Million - $4.3 Million	32,891 Added 0.73%	4,564,901 $591 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $83.5 Million - $99.6 Million	811,623 Added 21.82%	4,532,010 $513 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $19.9 Million - $24.8 Million	236,889 Added 6.8%	3,720,387 $385 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $644,153 - $742,315	-8,187 Reduced 0.23%	3,483,498 $291 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $7.73 Million - $9.83 Million	107,800 Added 3.19%	3,491,685 $319 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $8.66 Million - $11.3 Million	128,842 Added 3.96%	3,383,885 $270 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $128 Million - $171 Million	2,226,837 Added 216.57%	3,255,043 $225 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $30.4 Million - $47 Million	-580,243 Reduced 36.07%	1,028,206 $194 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $7.76 Million - $8.89 Million	108,253 Added 7.22%	1,608,449 $375 Million
Q3 2019 Nov 05, 2019	BUY	$61.55 - $75.43 $1.94 Million - $2.38 Million	31,515 Added 2.15%	1,500,196 $330 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $3.08 Million - $3.56 Million	55,196 Added 3.9%	1,468,681 $271 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $157,031 - $210,019	3,279 Added 0.23%	1,413,485 $270 Million
Q4 2018 Feb 08, 2019	SELL	$46.41 - $56.94 $33.3 Million - $40.8 Million	-716,792 Reduced 33.7%	1,410,206 $216 Million
Q3 2018 Oct 25, 2018	SELL	$45.7 - $58.03 $937,398 - $1.19 Million	-20,512 Reduced 0.96%	2,126,998 $370 Million
Q2 2018 Jul 30, 2018	BUY	$42.45 - $51.3 $4.57 Million - $5.52 Million	107,676 Added 5.28%	2,147,510 $313 Million
Q1 2018 May 04, 2018	BUY	$37.19 - $47.45 $203,280 - $259,361	5,466 Added 0.27%	2,039,834 $285 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $1.36 Million - $1.59 Million	40,365 Added 2.02%	2,034,368 $229 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $998,845 - $1.07 Million	27,524 Added 1.4%	1,994,003 $218 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,966,479	1,966,479 $233 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account